# DMT210 Topical Gel in the Treatment of Acne Rosacea

> **NCT03003104** · PHASE2 · COMPLETED · sponsor: **Dermata Therapeutics** · enrollment: 107 (actual)

## Conditions studied

- Acne Rosacea

## Interventions

- **DRUG:** DMT210 Topical Gel 5%
- **OTHER:** Vehicle Control

## Key facts

- **NCT ID:** NCT03003104
- **Lead sponsor:** Dermata Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-08-30
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003104, "DMT210 Topical Gel in the Treatment of Acne Rosacea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03003104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*